Caribou Biosciences, Inc. CRBU
CRBU
Caribou Biosciences, Inc. NTLA
Intellia Therapeutics, Inc. EDIT
Editas Medicine, Inc. CRSP
CRISPR Therapeutics AG VERV
Verve Therapeutics, Inc. BEAM
Beam Therapeutics Inc. FATE
Fate Therapeutics, Inc. PRME
Prime Medicine, Inc. SANA
Sana Biotechnology, Inc. ADPT
Adaptive Biotechnologies Corporation
Caribou Biosciences, Inc. NTLA
Intellia Therapeutics, Inc. EDIT
Editas Medicine, Inc. CRSP
CRISPR Therapeutics AG VERV
Verve Therapeutics, Inc. BEAM
Beam Therapeutics Inc. FATE
Fate Therapeutics, Inc. PRME
Prime Medicine, Inc. SANA
Sana Biotechnology, Inc. ADPT
Adaptive Biotechnologies Corporation
Performance
| Periode | CRBU | NTLA | EDIT | CRSP | VERV | BEAM | FATE | PRME | SANA | ADPT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 184.80 % | 230.90 % | 186.15 % | 85.99 % | 58.32 % | 70.14 % | 54.25 % | 327.07 % | 145.45 % | 91.06 % |
| YTD | 48.21 % | 100.65 % | 183.97 % | 76.43 % | 85.19 % | 6.56 % | -8.66 % | 89.97 % | 161.82 % | 145.07 % |
| 1Y | 31.05 % | 25.68 % | 14.81 % | 52.82 % | 117.81 % | -1.02 % | -46.39 % | 52.28 % | 7.73 % | 206.46 % |
| 3Y | -74.41 % | -55.51 % | -69.38 % | 25.90 % | -72.26 % | -46.29 % | -92.38 % | -63.04 % | -23.13 % | 134.83 % |
| 5Y | -84.74 % | -0.37 % | -88.65 % | -29.08 % | -65.13 % | -8.90 % | -96.67 % | -63.04 % | -87.69 % | -71.46 % |
| 10Y | -84.74 % | 10.95 % | -79.56 % | 418.77 % | -65.13 % | 40.37 % | -65.79 % | -63.04 % | -87.69 % | -62.36 % |
| From the beginning | -84.74 % | 10.95 % | -79.56 % | 418.77 % | -65.13 % | 40.37 % | -75.30 % | -63.04 % | -87.69 % | -62.36 % |